Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEPHROS INCNEPH · Entity 7279 | Director | November 10, 2025 | November 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEPHROS INC
Report date November 10, 2025 · Filed November 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,622 |
Reported balance
After 2025-11-10 transaction · row 1
1 source rowRow 1 · 2025-11-10 · Grant · Acquired 1,622 · Balance 1,622 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.49 · Expires 2035-08-11 | Direct | 13,229 |
Reported balance
Holding disclosure · report date 2025-11-10 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 13,229 F1: This option vests as to 4,410 shares on each of 6/16/25 and 6/16/26 and 4,409 options vest on 6/16/27. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests as to 4,410 shares on each of 6/16/25 and 6/16/26 and 4,409 options vest on 6/16/27.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2025 Filed Nov 13, 2025 17:00 UTC | NEPHROS INC NEPH · Entity 7279 | GrantCommon Stock | 1,622 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-25-000041 · form4.xml · nonDerivative · entry 1 Nettis Lisa Marie · CIK 0002076008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,622 Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 16:09 UTC | NEPHROS INC NEPH · Entity 7279 | GrantStock Option (right to buy) · Derivative | 13,229 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001062993-25-014297 · form4.xml · derivative · entry 1 Nettis Lisa Marie · CIK 0002076008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,229 Underlying: Common Stock · 13,229 shares Expires 2035-08-11 F1 · derivative.exercise_date: This option vests as to 4,410 shares on each of 6/16/25 and 6/16/26 and 4,409 options vest on 6/16/27. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.